- Investing Ideas
- /
- Bangladeshi Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Bangladeshi Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
2
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
2 companies
IBN SINA Pharmaceutical Industry
Market Cap: ৳9.6b
Produces and sells pharmaceutical drugs in Bangladesh and internationally.
IBNSINA
৳305.70
7D
3.7%
1Y
23.2%
Renata
Market Cap: ৳59.3b
Manufactures, markets, and distributes human pharmaceuticals, animal health medicines, nutritionals, and vaccines in Bangladesh.
RENATA
৳516.90
7D
5.8%
1Y
-30.1%